CI Canadian Convertible Bond ETF Common (TSE:CXF - Get Free Report)'s stock price traded up 1.1% during mid-day trading on Tuesday . The stock traded as high as C$10.00 and last traded at C$9.90. 12,659 shares traded hands during mid-day trading, an increase of 176% from the average session volume of 4,582 shares. The stock had previously closed at C$9.79.
CI Canadian Convertible Bond ETF Common Stock Performance
The business's 50 day simple moving average is C$10.03 and its 200 day simple moving average is C$10.11.
About CI Canadian Convertible Bond ETF Common
(
Get Free Report)
Chimerix, Inc, a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox.
Featured Articles
Before you consider CI Canadian Convertible Bond ETF Common, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CI Canadian Convertible Bond ETF Common wasn't on the list.
While CI Canadian Convertible Bond ETF Common currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
